HomeEUFA3 • BVMF
add
Eurofarma Laboratorios SA
Market news
Financials
Income Statement
Revenue
Net income
| (BRL) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 3.21B | 14.03% |
Operating expense | 1.41B | -8.77% |
Net income | 357.84M | 165.02% |
Net profit margin | 11.15 | 132.29% |
Earnings per share | — | — |
EBITDA | 825.36M | 89.77% |
Effective tax rate | 10.45% | — |
Balance Sheet
Total assets
Total liabilities
| (BRL) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.29B | -40.20% |
Total assets | 17.83B | 3.99% |
Total liabilities | 12.90B | 3.31% |
Total equity | 4.93B | — |
Shares outstanding | 989.21M | — |
Price to book | — | — |
Return on assets | 10.11% | — |
Return on capital | 12.00% | — |
Cash Flow
Net change in cash
| (BRL) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 357.84M | 165.02% |
Cash from operations | 502.28M | -4.09% |
Cash from investing | -127.54M | 62.89% |
Cash from financing | -576.73M | -404.59% |
Net change in cash | -212.73M | -163.15% |
Free cash flow | -231.08M | -15.34% |
About
Eurofarma is a Brazilian multinational corporation engaged in biopharmaceutical manufacturing and is one of the largest medicine producers in Brazil and Latin America. Founded in 1972, Eurofarma offers generic, oncologic and veterinary medications. Within Brazil the company is responsible for about 2000 products, representing 66% of the total market.
Eurofarma has active operations in 20 countries, with factories in Brazil, Argentina, Bolivia, Chile, Colombia, Ecuador, Guatemala, Mexico, Mozambique, Paraguay, Peru, Uruguay and Venezuela. Wikipedia
Founded
1972
Website
Employees
13,000
